{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:44:26Z","timestamp":1792172666902,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["31071989"],"award-info":[{"award-number":["31071989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0097-z","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T16:03:20Z","timestamp":1440432200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhu-Sheng","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Hong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam-Ming","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"97_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ypmed.2013.11.013","volume":"59","author":"A Manschot","year":"2014","unstructured":"Manschot A, van Oostrom SH, Smit HA, Verschuren WM, Picavet HS. Diagnosis of diabetes mellitus or cardiovascular disease and lifestyle changes - the Doetinchem cohort study. Prev Med. 2014;59:42\u20136.","journal-title":"Prev Med"},{"key":"97_CR2","author":"MS Burroughs Pe\u00f1a","year":"2012","unstructured":"Burroughs Pe\u00f1a MS, Patel D, Rodr\u00edguez Leyva D, Khan BV, Sperling L. Lifestyle risk factors and cardiovascular disease in Cubans and Cuban americans. Cardiol Res Pract. 2012. doi: 10.1155\/2012\/470705 .","journal-title":"Cardiol Res Pract"},{"key":"97_CR3","first-page":"203","volume":"11","author":"DJ Scherer","year":"2015","unstructured":"Scherer DJ, Nicholls SJ. Lowering triglycerides to modify cardiovascular risk. will icosapent deliver? Vasc Health Risk Manag. 2015;11:203\u20139.","journal-title":"Vasc Health Risk Manag"},{"issue":"5","key":"97_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","volume":"131","author":"AM Navar-Boggan","year":"2015","unstructured":"Navar-Boggan AM, Peterson ED, D'Agostino Sr RB, Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015;131(5):451\u20138.","journal-title":"Circulation"},{"key":"97_CR5","first-page":"1","volume":"6","author":"K Sharma","year":"2014","unstructured":"Sharma K, Kumar K, Mishra N. Nanoparticulate carrier system. a novel treatment approach for hyperlipidemia. Drug Deliv. 2014;6:1\u201316.","journal-title":"Drug Deliv"},{"issue":"14","key":"97_CR6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1517\/14656566.2014.946904","volume":"15","author":"V Hainer","year":"2014","unstructured":"Hainer V. Overview of new antiobesity drugs. Expert Opin Pharmacother. 2014;15(14):1975\u20138.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"97_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","volume":"311","author":"SZ Yanovski","year":"2014","unstructured":"Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74\u201386.","journal-title":"JAMA"},{"issue":"7","key":"97_CR8","first-page":"423","volume":"6","author":"B Mahgerefteh","year":"2013","unstructured":"Mahgerefteh B, Vigue M, Freestone Z, Silver S, Nguyen Q. New drug therapies for the treatment of overweight and obese patients. Am Health Drug Benefits. 2013;6(7):423\u201330.","journal-title":"Am Health Drug Benefits"},{"issue":"3","key":"97_CR9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/2156587214568457","volume":"20","author":"M Bahmani","year":"2015","unstructured":"Bahmani M, Mirhoseini M, Shirzad H, Sedighi M, Shahinfard N, Rafieian-Kopaei M. A review on promising natural agents effective on hyperlipidemia. J Evid Based Complementary Altern Med. 2015;20(3):228\u201338.","journal-title":"J Evid Based Complementary Altern Med"},{"key":"97_CR10","author":"MC Thounaojam","year":"2015","unstructured":"Thounaojam MC, Nammi S, Jadeja R. Natural products for the treatment of obesity, metabolic syndrome, and type 2 diabetes. Evid Based Complement Alternat Med. 2015. doi: 10.1155\/2015\/392681 .","journal-title":"Evid Based Complement Alternat Med"},{"key":"97_CR11","author":"SY Pan","year":"2014","unstructured":"Pan SY, Litscher G, Gao SH, Zhou SF, Yu ZL, Chen HQ, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complement Alternat Med. 2014. doi: 10.1155\/2014\/525340 .","journal-title":"Evid Based Complement Alternat Med"},{"key":"97_CR12","author":"SY Pan","year":"2013","unstructured":"Pan SY, Zhou SF, Gao SH, Yu ZL, Zhang SF, Tang MK, et al. New perspectives on hHow to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med. 2013. doi: 10.1155\/2013\/627375 .","journal-title":"Evid Based Complement Alternat Med"},{"issue":"9","key":"97_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.biopha.2007.08.018","volume":"61","author":"AY Yip","year":"2007","unstructured":"Yip AY, Loo WT, Chow LW. Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system - a Phase I minimization clinical trial. Biomed Pharmacother. 2007;61(9):588\u201390.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"97_CR14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.phymed.2009.02.004","volume":"16","author":"F Yan","year":"2009","unstructured":"Yan F, Zhang QY, Jiao L, Han T, Zhang H, Qin LP, et al. Synergistic hepatoprotective effect of Schisandrae lignans with Astragalus polysaccharides on chronic liver injury in rats. Phytomedicine. 2009;16(9):805\u201313.","journal-title":"Phytomedicine"},{"issue":"2","key":"97_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jep.2011.03.037","volume":"135","author":"DY Kwon","year":"2011","unstructured":"Kwon DY, da Kim S, Yang HJ, Park S. The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-\u03b3 pathways in in vitro and in vivo studies. J Ethnopharmacol. 2011;135(2):455\u201362.","journal-title":"J Ethnopharmacol"},{"key":"97_CR16","author":"PY Lam","year":"2012","unstructured":"Lam PY, Ko KM. Schisandrin B as a hermetic agent for preventing age-related neurodegenerative diseases. Oxid Med Cell Longev. 2012. doi: 10.1155\/2012\/250825 .","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"97_CR17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jep.2006.10.008","volume":"110","author":"F Huang","year":"2007","unstructured":"Huang F, Xiong Y, Xu L, Ma S, Dou C. Sedative and hypnotic activities of the ethanol fraction from Fructus Schisandrae in mice and rats. J Ethnopharmacol. 2007;110(3):471\u20135.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"97_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15430\/JCP.2014.19.4.279","volume":"19","author":"YS Kang","year":"2014","unstructured":"Kang YS, Han MH, Hong SH, Park C, Hwang HJ, Kim BW, et al. Anti-inflammatory Effects of Schisandra chinensis (Turcz.) Baill Fruit Through the Inactivation of Nuclear Factor-\u03baB and Mitogen-activated Protein Kinases Signaling Pathways in Lipopolysaccharide-stimulated Murine Macrophages. J Cancer Prev. 2014;19(4):279\u201387.","journal-title":"J Cancer Prev"},{"key":"97_CR19","first-page":"1429","volume":"8","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Pan SY, Zhou SF, Wang XY, Sun N, Zhu PL, et al. Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice. Drug Des Devel Ther. 2014;8:1429\u201339.","journal-title":"Drug Des Devel Ther"},{"key":"97_CR20","first-page":"923","volume":"9","author":"PL Zhu","year":"2015","unstructured":"Zhu PL, Pan SY, Zhou SF, Zhang Y, Wang XY, Sun N, et al. Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice. Drug Des Devel Ther. 2015;9:923\u201335.","journal-title":"Drug Des Devel Ther"},{"key":"97_CR21","author":"XY Wang","year":"2014","unstructured":"Wang XY, Yu ZL, Pan SY, Zhang Y, Sun N, Zhu PL, et al. Supplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic diet. Evid Based Complement Alternat Med. 2014. doi: 10.1155\/2014\/472638 .","journal-title":"Evid Based Complement Alternat Med"},{"key":"97_CR22","author":"HY Kwan","year":"2015","unstructured":"Kwan HY, Niu X, Dai W, Tong T, Chao X, Su T, et al. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers. Sci Rep. 2015. doi: 10.1038\/srep09114 .","journal-title":"Sci Rep"},{"issue":"3","key":"97_CR23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/pr3010327","volume":"12","author":"HY Kwan","year":"2013","unstructured":"Kwan HY, Hu YM, Chan CL, Cao HH, Cheng CY, Pan SY, et al. Lipidomics identification of metabolic biomarkers in chemically induced hypertriglyceridemic mice. J Proteome Res. 2013;12(3):1387\u201398.","journal-title":"J Proteome Res"},{"issue":"1","key":"97_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00003495-200767010-00013","volume":"67","author":"GM Keating","year":"2007","unstructured":"Keating GM, Croom KF. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus. Drugs. 2007;67(1):121\u201353.","journal-title":"Drugs"},{"issue":"4","key":"97_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/laban.710","volume":"44","author":"YG Madariaga","year":"2015","unstructured":"Madariaga YG, C\u00e1rdenas MB, Irsula MT, Alfonso OC, C\u00e1ceres BA, Morgado EB. Assessment of four experimental models of hyperlipidemia. Lab Anim (NY). 2015;44(4):135\u201340.","journal-title":"Lab Anim (NY)"},{"issue":"3","key":"97_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13105-010-0029-3","volume":"66","author":"R Mateo-Gallego","year":"2010","unstructured":"Mateo-Gallego R, Solanas-Barca M, Burillo E, Cenarro A, Marques-Lopes I, Civeira F. Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia. J Physiol Biochem. 2010;66(3):229\u201336.","journal-title":"J Physiol Biochem"},{"issue":"10","key":"97_CR27","first-page":"1257","volume":"96","author":"S Thiengwiboonwong","year":"2013","unstructured":"Thiengwiboonwong S, Chongsuwat R, Temcharoen P, Pandii W, Pavadhgul P. Efficacy of dietary modification following the National Cholesterol Education Program (NCEP) recommendation on lipid profiles among hyperlipidemia subjects. J Med Assoc Thai. 2013;96(10):1257\u201367.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"97_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12013-014-0203-2","volume":"71","author":"T Wu","year":"2015","unstructured":"Wu T, Chen G, Chen X, Wang Q, Wang G. Anti-hyperlipidemic and anti-oxidative effects of Gelsemine in high-fat-diet-fed rabbits. Cell Biochem Biophys. 2015;71(1):337\u201344.","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"97_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2265.1988.tb03651.x","volume":"28","author":"BU Althaus","year":"1988","unstructured":"Althaus BU, Staub JJ, Ryff-De L\u00e8che A, Oberh\u00e4nsli A, St\u00e4helin HB. LDL\/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988;28(2):157\u201363.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"97_CR30","doi-asserted-by":"crossref","first-page":"502948","DOI":"10.1155\/2013\/502948","volume":"2013","author":"L Baruch","year":"2013","unstructured":"Baruch L, Chiong VJ, Agarwal S, Gupta B. Discordance of non-HDL and directly measured LDL cholesterol: Which lipid measure is preferred when calculated LDL is inaccurate? Cholesterol. 2013;2013:502948.","journal-title":"Cholesterol"},{"issue":"5","key":"97_CR31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4103\/2230-8210.139217","volume":"18","author":"CC Onyedum","year":"2014","unstructured":"Onyedum CC, Young EE, Iroezindu MO, Chukwuka CJ, Nwagha UI. Atherogenic index of plasma in highly active antiretroviral therapy-na\u00efve patients with human immunodeficiency virus infection in Southeast Nigeria. Indian J Endocrinol Metab. 2014;18(5):631\u20136.","journal-title":"Indian J Endocrinol Metab"},{"key":"97_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S004393391300007X","volume":"69","author":"OW Willems","year":"2013","unstructured":"Willems OW, Miller SP, Wood BJ. Aspects of selection for feed efficiency in meat producing poultry. World\u2019s Poult Sci J. 2013;69:77\u201388.","journal-title":"World\u2019s Poult Sci J"},{"issue":"3","key":"97_CR33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S1751731114002997","volume":"9","author":"EE Connor","year":"2015","unstructured":"Connor EE. Invited review: improving feed efficiency in dairy production: challenges and possibilities. Animal. 2015;9(3):395\u2013408.","journal-title":"Animal"},{"key":"97_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-animal-022513-114132","volume":"2","author":"PB Siegel","year":"2014","unstructured":"Siegel PB. Evolution of the modern broiler and feed efficiency. Annu Rev Anim Biosci. 2014;2:375\u201385.","journal-title":"Annu Rev Anim Biosci"},{"key":"97_CR35","author":"N Zhou","year":"2015","unstructured":"Zhou N, Lee WR, Abasht B. Messenger RNA sequencing and pathway analysis provide novel insights into the biological basis of chickens' feed efficiency. BMC Genomics. 2015. doi: 10.1186\/s12864-015-1364-0 .","journal-title":"BMC Genomics"},{"key":"97_CR36","author":"H Ju","year":"2015","unstructured":"Ju H, Zhang J, Bai L, Mu Y, Du Y, Yang W, et al. The transgenic cloned pig population with integrated and controllable GH expression that has higher feed efficiency and meat production. Sci Rep. 2015. doi: 10.1038\/srep10152 .","journal-title":"Sci Rep"},{"issue":"12","key":"97_CR37","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.clinthera.2009.12.007","volume":"31","author":"MH Davidson","year":"2009","unstructured":"Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, et al. Efficacy and tolerability of atorvastatin\/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Clin Ther. 2009;31(12):2824\u201338.","journal-title":"Clin Ther"},{"issue":"9","key":"97_CR38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","volume":"5","author":"MS Kostapanos","year":"2013","unstructured":"Kostapanos MS, Kei A, Elisaf MS. Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. World J Hepatol. 2013;5(9):470\u20138.","journal-title":"World J Hepatol"},{"issue":"4","key":"97_CR39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11745-015-3999-7","volume":"50","author":"JL Zheng","year":"2015","unstructured":"Zheng JL, Luo Z, Hu W, Pan YX, Zhuo MQ. Dietary fenofibrate reduces hepatic lipid deposition by regulating lipid metabolism in yellow catfish pelteobagrus fulvidraco exposed to waterborne zn. Lipids. 2015;50(4):417\u201326.","journal-title":"Lipids"},{"issue":"5","key":"97_CR40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2710.2009.01029.x","volume":"34","author":"D Hajdu","year":"2009","unstructured":"Hajdu D, Aiglov\u00e1 K, Vinklerov\u00e1 I, Urb\u00e1nek K. Acute cholestatic hepatitis induced by fenofibrate. J Clin Pharm Ther. 2009;34(5):599\u2013602.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"97_CR41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2131\/jts.34.377","volume":"34","author":"A Kobayashi","year":"2009","unstructured":"Kobayashi A, Suzuki Y, Kuno H, Sugai S, Sakakibara H, Shimoi K. Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats. J Toxicol Sci. 2009;34(4):377\u201387.","journal-title":"J Toxicol Sci"},{"key":"97_CR42","author":"SY Pan","year":"2012","unstructured":"Pan SY, Yu Q, Zhang Y, Wang XY, Sun N, Yu ZL, et al. Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum\/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids Health Dis. 2012. doi: 10.1186\/1476-511X-11-120 .","journal-title":"Lipids Health Dis"},{"issue":"5","key":"97_CR43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2095-4964(14)60039-X","volume":"12","author":"CQ Zhao","year":"2014","unstructured":"Zhao CQ, Zhou Y, Ping J, Xu LM. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med. 2014;12(5):401\u20138.","journal-title":"J Integr Med"},{"key":"97_CR44","author":"J Zhang","year":"2015","unstructured":"Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med. 2015. doi: 10.1155\/2015\/316706 .","journal-title":"Evid Based Complement Alternat Med"},{"key":"97_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jep.2015.02.051","volume":"166","author":"S Zhang","year":"2015","unstructured":"Zhang S, Wang R, Zeng W, Zhu W, Zhang X, Wu C, et al. Resource investigation of traditional medicinal plant Panax japonicus (T. Nees) CA Mey and its varieties in China. J Ethnopharmacol. 2015;166:79\u201385.","journal-title":"J Ethnopharmacol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0097-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T21:24:08Z","timestamp":1653081848000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/14\/1\/93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["97"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0097-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]},"article-number":"93"}}